Exozymes EXOZ
NASDAQ EXOZ
$7.04 +0.64 (+10.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Exozymes (EXOZ) Operating Leases (2023 - 2026)

Exozymes (EXOZ) posted quarterly Operating Leases of $852575.0 for Q4 2025, down 38.52% year-over-year from $1.4 million in Q4 2024, and down 7.99% quarter-over-quarter from $926587.0 in Q3 2025.

Exozymes (EXOZ) Operating Leases (2023 - 2026) Analysis & Trends

Exozymes (EXOZ) has reported Operating Leases for 3 consecutive years, with $852575.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Operating Leases fell 38.52% year-over-year to $852575.0; the TTM figure through Dec 2025 stood at $852575.0 (down 38.52% YoY), while the FY2025 annual figure was $852575.0, down 38.52% from the prior year.
  • Operating Leases eased to $852575.0 in Q4 2025 per EXOZ's latest filing, from $926587.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $1.6 million in Q4 2023 and bottomed at $852575.0 in Q4 2025.
  • Historically, Operating Leases has averaged $1.2 million across 3 years, with a median of $1.1 million in 2025.
  • Annual changes were most pronounced in 2024 — Operating Leases retreated 13.96% — and 2025, when it sank 38.52%.
  • Exozymes' Operating Leases stood at $1.6 million in 2023, then dropped by 13.96% to $1.4 million in 2024, then tumbled by 38.52% to $852575.0 in 2025.
  • Business Quant data shows EXOZ's Operating Leases at $852575.0 in Q4 2025, $926587.0 in Q3 2025, and $1.0 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn -
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn
10 Exozymes 61.53 Mn 61.53 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 998,065.00
Dec 31, 2025 852,575.00
Sep 30, 2025 926,587.00
Jun 30, 2025 1.02 Mn
Mar 31, 2025 1.09 Mn
Dec 31, 2024 1.39 Mn
Sep 30, 2024 1.22 Mn
Dec 31, 2023 1.61 Mn